Drug makers may profit from disease in global warming scourge

on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on
The former Hungarian PM’s “propaganda machine” has returned with “a new look”, says Greens MEP Daniel Freund.
on
Ben Delo and Christopher Harborne aren’t the party’s only big money backers.
Analysis
on
Financiers with short-term incentives can profit big even if the west coast pipeline pushed by Mark Carney and Alberta costs taxpayers billions.
on
The Ferguson Group is one among dozens of companies working both sides of the climate crisis, according to research by campaigners.